You are here: Industry Insights > Market News > Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Riociguat(625115-55-1)

Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate

2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)

4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-

1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

expresspharmaApril 30, 2021

Tag: Covaxin , Bharat Biotech , Serum Institute of India

Favorites

Bharat Biotech has slashed the price of its COVID-19 vaccine Covaxin for state governments from ₹600 to ₹400 per dose, the company said in a statement. The price of Covaxin for private healthcare providers is ₹1,200 per dose.

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

The announcement came one day after the Serum Institute of India, reduced the price of Covishield from ₹400 to ₹300.

“Bharat Biotech is deeply concerned with the critical pandemic circumstances that India is facing at this time. Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of ₹ 400 per dose,” the company said in a statement.

Previous:Pfizer Acquires Amplyx Pharmaceuticals

Next:Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Innovent Biologics announced that China's National Medical Products Administration (NMPA) has approved a New Drug Application (NDA) of DOVBLERON ® .

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

Related News

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

You may like
More>>

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

Related News

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

You may likeMore>>

You may like
More>>